Rochester Medical (ROCM)

Must be logged in to add this company to your watchlist.

Click here to login.

ROCM - NASDAQ - 3/11/2010 6:54 PM

12.58
Change 0.23
% Change 1.86%
Market Cap Revenue Growth Profit Margin Cash
$150.55M 21.21% -1.66% $36.26M
3112 / 4696 612 / 4687 3318 / 4693 2397 / 4139

For the December 2009 quarter, Rochester Medical spent 9.54% of gross profits on R&D and 96.75% on SGA expenses. Revenues rose 21.21% year-over-year to $10.23M. The company is trading at an unknown amount times earnings(PE) and 4.11 times revenue(PSR). At the end of December 2009, Rochester Medical had $36.26M in cash on hand and $1.04M in long-term debt. On 01/26/2010, Rochester Medical reported net loss of $0.17M, with diluted earnings per share of $-0.01.

Valuation

Add More Charts

Price

Current stock price.

PE Ratio

Price paid for a share relative to the annual income earned.

Price to Sales Ratio: 4.11

Market cap divided by revenue.

Growth & Profitability

Add More Charts

Revenue Growth: 21.21%

Revenue growth year-over-year.

Earnings per Share: $-0.01

Portion of profit allocated to each outstanding share of common stock.

Profit Margin: -1.66%

Margin made on every dollar of revenue.

Fundamentals

Add More Charts

Income Statement

Summary of revenues, expenses & profits.

Balance Sheet

Company's assets, liabilities & shareholders' equity at a specific point in time.

Cash Flow

Cash inflows arise from one of three activities - operations, financing, or investing.